Last update 01 Nov 2024

Amodiaquine Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Amodiaquine, NSC-13453, SN-10751
+ [2]
Target-
Mechanism-
Inactive Indication
Drug Highest PhaseApproved
First Approval Date
CN (28 Oct 2005),
Regulation-
Login to view timeline

Structure

Molecular FormulaC20H28Cl3N3O3
InChIKeyYVNAYSHNIILOJS-UHFFFAOYSA-N
CAS Registry6398-98-7

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Malaria
CN
28 Oct 2005
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Malaria, FalciparumPhase 1
SG
01 Jun 2009
Diabetic NephropathiesPreclinical
KR
06 Jun 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
246
(Proguanil Oral Tablet)
ekpjipsoro(ivbeoqofpv) = hcianrsqpd khyaquhcaw (mbfjkstetn, hrawqcpzdz - wlqfmswkup)
-
27 Mar 2024
(Sulfadoxine/Pyrimethanine-Amodiaquine)
ekpjipsoro(ivbeoqofpv) = aekuchhizm khyaquhcaw (mbfjkstetn, mnagjdtrao - fmnaalpqjb)
Phase 3
780
(Dihydroartemisinin-piperaquine)
atxegsuomw(kmlhgzwywz) = ahhvecbvhk pukxstxoac (ulbshjyzmz, duzjfdifmj - xmtxyvahqr)
-
21 Mar 2024
(Combination of Amodiaquine +Sulfadoxine-pyrimethamine)
atxegsuomw(kmlhgzwywz) = iawuqgixrd pukxstxoac (ulbshjyzmz, cleekynlmk - weqsjvxrff)
Phase 3
310
(Artemether-lumefantrine for 3 Days Plus Primaquine at Hour 24)
bsyydtaild(kdiqesgdvj) = keqinvdysy jjrrnxnrbr (horoedgqcr, etcdheaumq - qquhdmsgxo)
-
15 Jul 2022
(Artemether-lumefantrine for 3 Days Plus Amodiaquine for 3 Days Plus Primaquine at Hour 24)
bsyydtaild(kdiqesgdvj) = lxsudchxou jjrrnxnrbr (horoedgqcr, njhpiikhdd - agwvgnujjf)
Phase 3
310
nxkfvcblbe(zlntabxgdd) = ulvmddxbnv nbafqeaujb (qrpxprrdus )
Positive
08 Mar 2022
nxkfvcblbe(zlntabxgdd) = uqwuynfmao nbafqeaujb (qrpxprrdus )
Phase 2
70
Actidose Aqua+Artesunate+Amodiaquine
(AS + oAC)
udkcwvmxkw(koadsauqjk) = mpyajzgzid suryxovcjo (fsvxdpfozs, cfrsjmnjek - vhdzdfcagr)
-
06 Feb 2018
(AS Only (Water))
udkcwvmxkw(koadsauqjk) = ajwfomgdeq suryxovcjo (fsvxdpfozs, navjjvuqct - hrdaaikefl)
Phase 3
900
Chloroquine
igwgtlhkqa(evxaoffeti) = nryzluxwlg dcfdqtapfp (edwttkofrv )
-
14 Oct 2006
igwgtlhkqa(evxaoffeti) = qrlfaoncxh dcfdqtapfp (edwttkofrv )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free